Literature DB >> 1322135

Inhibition of Escherichia coli DNA topoisomerase I activity by phospholipids.

T Mizushima1, S Natori, K Sekimizu.   

Abstract

The DNA relaxation activity of Escherichia coli DNA topoisomerase I in vitro was greatly inhibited by cardiolipin. Inhibition also occurred to some extent with phosphatidylglycerol from egg yolk. Analysis with synthetic phospholipid revealed that phosphatidylglycerol containing unsaturated fatty acids exhibited a strong inhibitory effect, whereas inhibition by phosphatidylglycerol containing saturated fatty acids was weak. Phosphatidylethanolamine showed no inhibitory effect. Chlorpromazine, which interacts with phospholipids, suppressed the inhibitory effect of cardiolipin. Cardiolipin and phosphatidylglycerol with unsaturated fatty acid precipitated topoisomerase I even at low concentrations, whereas phosphatidylglycerol from egg yolk and a synthetic phosphatidylglycerol containing saturated fatty acids precipitated this enzyme only at high concentrations. One-third of the total topoisomerase I in E. coli was found in the membrane fraction. Treatment of E. coli cells with chlorpromazine resulted in relaxation of plasmid DNA. This DNA relaxation was not observed in a topA mutant, suggesting that this relaxation by chlorpromazine in vivo is catalysed by topoisomerase I.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1322135      PMCID: PMC1132816          DOI: 10.1042/bj2850503

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

1.  The beta-d-galactosidase of Escherichia coli, strain K-12.

Authors:  J LEDERBERG
Journal:  J Bacteriol       Date:  1950-10       Impact factor: 3.490

2.  A subthreshold level of DNA topoisomerases leads to the excision of yeast rDNA as extrachromosomal rings.

Authors:  R A Kim; J C Wang
Journal:  Cell       Date:  1989-06-16       Impact factor: 41.582

3.  A physiological role for DNA supercoiling in the osmotic regulation of gene expression in S. typhimurium and E. coli.

Authors:  C F Higgins; C J Dorman; D A Stirling; L Waddell; I R Booth; G May; E Bremer
Journal:  Cell       Date:  1988-02-26       Impact factor: 41.582

4.  DNA supercoiling and the anaerobic and growth phase regulation of tonB gene expression.

Authors:  C J Dorman; G C Barr; N Ni Bhriain; C F Higgins
Journal:  J Bacteriol       Date:  1988-06       Impact factor: 3.490

5.  The dnaA protein of Escherichia coli. Abundance, improved purification, and membrane binding.

Authors:  K Sekimizu; B Y Yung; A Kornberg
Journal:  J Biol Chem       Date:  1988-05-25       Impact factor: 5.157

6.  Inhibitory action of phospholipid-interacting drugs on transcription initiation in a nuclear extract of Ehrlich ascites tumor cells.

Authors:  H Hirai; S Natori; K Sekimizu
Journal:  Biochim Biophys Acta       Date:  1991-02-16

7.  Proton motive force-dependent and -independent protein translocation revealed by an efficient in vitro assay system of Escherichia coli.

Authors:  H Yamada; H Tokuda; S Mizushima
Journal:  J Biol Chem       Date:  1989-01-25       Impact factor: 5.157

8.  Acidic phospholipids directly inhibit DNA binding of mammalian DNA topoisomerase I.

Authors:  H Tamura; Y Ikegami; K Ono; K Sekimizu; T Andoh
Journal:  FEBS Lett       Date:  1990-02-12       Impact factor: 4.124

9.  Binding of simian virus 40 large tumor antigen to phospholipid vesicles.

Authors:  H Hirai; N Takahashi; S Natori; K Sekimizu
Journal:  Biochim Biophys Acta       Date:  1991-11-11

10.  Inhibitory action of chlorpromazine, dibucaine, and other phospholipid-interacting drugs on calcium-activated, phospholipid-dependent protein kinase.

Authors:  T Mori; Y Takai; R Minakuchi; B Yu; Y Nishizuka
Journal:  J Biol Chem       Date:  1980-09-25       Impact factor: 5.157

View more
  10 in total

1.  Suppression of temperature-sensitivity of a dnaA46 mutant by excessive DNA supercoiling.

Authors:  T Kondo; S Mima; N Fukuma; K Sekimizu; T Tsuchiya; T Mizushima
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

2.  Cardiolipin Interactions with Proteins.

Authors:  Joan Planas-Iglesias; Himal Dwarakanath; Dariush Mohammadyani; Naveena Yanamala; Valerian E Kagan; Judith Klein-Seetharaman
Journal:  Biophys J       Date:  2015-08-20       Impact factor: 4.033

3.  Escherichia coli DNA topoisomerase I and suppression of killing by Tn5 transposase overproduction: topoisomerase I modulates Tn5 transposition.

Authors:  H Yigit; W S Reznikoff
Journal:  J Bacteriol       Date:  1998-11       Impact factor: 3.490

4.  Identification of DNA topoisomerases involved in immediate and transient DNA relaxation induced by heat shock in Escherichia coli.

Authors:  Y Ogata; T Mizushima; K Kataoka; T Miki; K Sekimizu
Journal:  Mol Gen Genet       Date:  1994-09-01

5.  The Neisseria gonorrhoeae photolyase orthologue phrB is required for proper DNA supercoiling but does not function in photo-reactivation.

Authors:  Laty A Cahoon; Elizabeth A Stohl; H Steven Seifert
Journal:  Mol Microbiol       Date:  2010-12-13       Impact factor: 3.501

6.  The RcsCB His-Asp phosphorelay system is essential to overcome chlorpromazine-induced stress in Escherichia coli.

Authors:  Annie Conter; Rachel Sturny; Claude Gutierrez; Kaymeuang Cam
Journal:  J Bacteriol       Date:  2002-05       Impact factor: 3.490

Review 7.  New advances in fatty acids as antimalarial, antimycobacterial and antifungal agents.

Authors:  N M Carballeira
Journal:  Prog Lipid Res       Date:  2007-11-01       Impact factor: 16.195

Review 8.  Functions of the gene products of Escherichia coli.

Authors:  M Riley
Journal:  Microbiol Rev       Date:  1993-12

9.  An improved synthesis for the (Z)-14-methyl-9-pentadecenoic acid and its topoisomerase I inhibitory activity.

Authors:  Néstor M Carballeira; David Sanabria; Delise Oyola
Journal:  ARKIVOC       Date:  2007       Impact factor: 1.140

Review 10.  Bacterial topoisomerase I as a target for discovery of antibacterial compounds.

Authors:  Yuk-Ching Tse-Dinh
Journal:  Nucleic Acids Res       Date:  2008-11-28       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.